Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05780099 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prospective Observational Study to Characterize Patients Treated at Internal Medicine Clinics

Study acronym: MED-Cli
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv4
  2. Study description expanded, about 309 wordsv3
  3. Primary endpoint revisedv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
IRCCS San Raffaele
234 trials monitored
See 1 trial at risk
Heart Disease
8,786 trials monitored
See 412 trials at risk
Patients referred to internal medicine wards are becoming increasingly complex and fragile. Despite deep knowledge of their specific disorders, steps are required to improve overall management of their acute and chronic conditions. The main objective of the study is to identify demographic, clinical, laboratory and radiological markers of disease severity and activity in patients with diseases treated at general medicine wards (respiratory disease, immune-mediated disease, sepsis, metabolic disease, rare disease, frailty, pregnancy pathology) in order to improve their diagnosis, monitoring and treatment processes.
Trial Details
NCT Number NCT05780099
Lead Sponsor IRCCS San Raffaele
Conditions
(from sponsor)		 Respiratory Disease, Cardiovascular Diseases, Infectious Disease, Critical Illness, Immunological Disease, Pregnancy Disease, Metabolic Syndrome, Chronic Disease
Related terms Cardiovascular Diseases, Chronic Disease, Communicable Diseases, Critical Illness, Immune System Diseases, Metabolic Syndrome, Respiration Disorders
Enrollment 50,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov